CROSPOVIDONE (15 MPA.S AT 5%)
Unresolved Excipient
Suggest One
No specific molecular structure known for this excipient.
- CAS
- 9003398
- UNII
- 68401960MK
- SYNONYMS
-
- ZINC ID(s)
-
- Availability
- Present in 0 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Analogs cannot be located as there is no structure provided for this compound. Try a
search by name.
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Implantation | Pellet | 2MG |
| Intra-Articular | Injection | 0.02% |
| Intramuscular | Injection | 0.02% |
| Intrauterine | Solution | |
| Oral | Capsule | 67MG |
| Oral | Capsule (immed./comp. Release), Hard Gelatin | 15.91MG |
| Oral | Capsule, Coated, Soft Gelatin | 14MG |
| Oral | Capsule, Delayed Action | 5MG |
| Oral | Capsule, Enteric Coated Pellets | 20.25MG |
| Oral | Capsule, Hard Gelatin | 70MG |
| Oral | Capsule, Sustained Action | 10.71MG |
| Oral | Dispersible Tablet | 340MG |
| Oral | Granule, For Oral Suspension | 75MG |
| Oral | Pellet | 75MG |
| Oral | Powder, For Suspension | 5% |
| Oral | Suspension | 0.05% |
| Oral | Suspension, Sustained Action | 18.68% |
| Oral | Tablet | 15MG |
| Oral | Tablet (immed./comp. Release), Coated | 14MG |
| Oral | Tablet (immed./comp. Release), Film Coated | 110MG |
| Oral | Tablet (immed./comp. Release), Uncoated, Buccal | 9.6MG |
| Oral | Tablet (immed./comp. Release), Uncoated, Chewable | 100MG |
| Oral | Tablet, Coated | 104MG |
| Oral | Tablet, Controlled Release | |
| Oral | Tablet, Delayed Action | 84MG |
| Oral | Tablet, Delayed Action, Enteric Coated | 50MG |
| Oral | Tablet, Delayed Release | 31.72MG |
| Oral | Tablet, Dispersible | 10MG |
| Oral | Tablet, Enteric Coated Particles | 130MG |
| Oral | Tablet, Extended Release | 39.2MG |
| Oral | Tablet, Film Coated | 196.7MG |
| Oral | Tablet, Film Coated, Extended Release | 12MG |
| Oral | Tablet, For Suspension | 125MG |
| Oral | Tablet, Multilayer, Extended Release | 5MG |
| Oral | Tablet, Orally Disintegrating | 180MG |
| Oral | Tablet, Orally Disintegrating, Delayed Release | 15MG |
| Oral | Tablet, Repeat Action | 10MG |
| Oral | Tablet, Sustained Action | 144MG |
| Oral | Tablet, Sustained Action, Coated | 15.4MG |
| Oral | Tablet, Sustained Action, Film Coated | 5MG |
| Oral-21 | Tablet | 4.45MG |
| Sublingual | Tablet | 24.87MG |
| Sublingual | Tablet (immed./comp. Release), Uncoated, Buccal | 16MG |
| Topical | Emulsion | 1% |
| Topical | Lotion | |
| Transdermal | Film | 3.63MG |
| Transdermal | Film, Controlled Release | 60MG |
| Transdermal | Patch, Electrically Controlled | 62MG |
| Vaginal | Suppository | 116.1MG |
| Vaginal | Tablet | 50MG |